Cencora
Cencora, formerly AmerisourceBergen, is a global pharmaceutical solutions organization active in logistics, distribution and clinical development support, which invests in emerging healthcare businesses through Cencora Ventures.
Cencora invests in emerging healthcare businesses through Cencora Ventures, the corporate venture arm of a global pharmaceutical solutions organization. The parent company, formerly AmerisourceBergen and renamed Cencora in August 2023, was founded in 1871 and provides end-to-end services across the healthcare spectrum - pharmaceutical logistics and warehousing, wholesale and specialty distribution, drug research and clinical development support, commercialization support, and patient access and adherence services. Specific investment criteria, stages and check sizes for Cencora Ventures are not disclosed in the material available here.
The operating business spans more than 50 countries, employs over 46,000 team members and serves over 100,000 locations across human and animal health. Annual revenue exceeds $290 billion, and the company ranks #10 on the Fortune 500. Solutions are organised by customer type, including pharmacy solutions, hospital and health system solutions, and specialty distribution.
Technical domains of the wider organisation cover pharmaceutical logistics and warehousing, clinical development support, commercialization, patient access and adherence, and pharmacy, hospital and health system solutions. Industry verticals include pharmaceutical distribution and manufacturing, drug wholesale, pharmacy, hospitals and health systems, and human and animal health.
The stated mission is improving the lives of people and animals everywhere, with a commitment to ensuring access to needed therapies. The rebrand to Cencora in August 2023 was intended to reflect the company's global role.